Zussman BD - Search Results

1

An overview of the pharmacokinetics of cilomilast (Ariflo), a new, orally active phosphodiesterase 4 inhibitor, in healthy young and elderly volunteers.

Zussman BD, Benincosa LJ, Webber DM, Clark DJ, Cowley H, Kelly J, Murdoch RD, Upward J, Wyld P, Port A, Fuder H. Zussman BD, et al. J Clin Pharmacol. 2001 Sep;41(9):950-8. doi: 10.1177/00912700122010924. J Clin Pharmacol. 2001. PMID: 11549099 Clinical Trial.

2

Lack of pharmacokinetic interactions between cilomilast and theophylline or smoking in healthy volunteers.

Murdoch RD, Zussman B, Schofield JP, Webber DM. Murdoch RD, et al. J Clin Pharmacol. 2004 Sep;44(9):1046-53. doi: 10.1177/0091270004266488. J Clin Pharmacol. 2004. PMID: 15317832 Clinical Trial.

3

Pharmacokinetics and tolerability of ascending intravenous doses of granisetron, a novel 5-HT3 antagonist, in healthy human subjects.

Allen A, Asgill CC, Pierce DM, Upward J, Zussman BD. Allen A, et al. Among authors: zussman bd. Eur J Clin Pharmacol. 1994;46(2):159-62. doi: 10.1007/BF00199881. Eur J Clin Pharmacol. 1994. PMID: 8039536 Clinical Trial.

4

Bioavailability of the oral selective phosphodiesterase 4 inhibitor cilomilast.

Zussman BD, Davie CC, Kelly J, Murdoch RD, Clark DJ, Schofield JP, Walls C, Birrell C, Webber D, Quinlan J, Ritchie SY, Carr A. Zussman BD, et al. Pharmacotherapy. 2001 Jun;21(6):653-60. doi: 10.1592/phco.21.7.653.34569. Pharmacotherapy. 2001. PMID: 11401178 Clinical Trial.

5

Cilomilast: pharmacokinetic and pharmacodynamic interactions with digoxin.

Zussman BD, Kelly J, Murdoch RD, Clark DJ, Mbchb, Schubert C, Collie H. Zussman BD, et al. Clin Ther. 2001 Jun;23(6):921-31. doi: 10.1016/s0149-2918(01)80079-5. Clin Ther. 2001. PMID: 11440291 Clinical Trial.

6

Paroxetine does not affect the cardiac safety and pharmacokinetics of terfenadine in healthy adult men.

Martin DE, Zussman BD, Everitt DE, Benincosa LJ, Etheredge RC, Jorkasky DK. Martin DE, et al. Among authors: zussman bd. J Clin Psychopharmacol. 1997 Dec;17(6):451-9. doi: 10.1097/00004714-199712000-00003. J Clin Psychopharmacol. 1997. PMID: 9408807 Clinical Trial.

7

Linear pharmacokinetic behavior of ropinirole during multiple dosing in patients with Parkinson's disease.

Hubble J, Koller WC, Atchison P, Taylor AC, Citerone DR, Zussman BD, Friedman CJ, Hawker N. Hubble J, et al. Among authors: zussman bd. J Clin Pharmacol. 2000 Jun;40(6):641-6. J Clin Pharmacol. 2000. PMID: 10868315

8

The pharmacokinetics of paroxetine in renal impairment.

Doyle GD, Laher M, Kelly JG, Byrne MM, Clarkson A, Zussman BD. Doyle GD, et al. Among authors: zussman bd. Acta Psychiatr Scand Suppl. 1989;350:89-90. doi: 10.1111/j.1600-0447.1989.tb07181.x. Acta Psychiatr Scand Suppl. 1989. PMID: 2530798 Clinical Trial. No abstract available.

9

The pharmacokinetics of paroxetine in the elderly.

Bayer AJ, Roberts NA, Allen EA, Horan M, Routledge PA, Swift CG, Byrne MM, Clarkson A, Zussman BD. Bayer AJ, et al. Among authors: zussman bd. Acta Psychiatr Scand Suppl. 1989;350:85-6. doi: 10.1111/j.1600-0447.1989.tb07179.x. Acta Psychiatr Scand Suppl. 1989. PMID: 2530796 No abstract available.

10

A review of the metabolism and pharmacokinetics of paroxetine in man.

Kaye CM, Haddock RE, Langley PF, Mellows G, Tasker TC, Zussman BD, Greb WH. Kaye CM, et al. Among authors: zussman bd. Acta Psychiatr Scand Suppl. 1989;350:60-75. doi: 10.1111/j.1600-0447.1989.tb07176.x. Acta Psychiatr Scand Suppl. 1989. PMID: 2530793 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters